Manufacturing Facility Milestone at Wakiso

The NAROVAC production facility has achieved important manufacturing-readiness milestones. These advances support the pathway toward producing the anti-tick vaccine at scale in Uganda.

Facility readiness, quality assurance and supply arrangements remain key priorities for the programme.